Opsona Therapeutics Limited was set up on Tuesday the 9th of March 2004. Their current address is 2nd Floor Ashford House,Tara Street,Dublin 2, and the company status is Strike Off Listed. The company has 9 directors who have also been the director of 13 other Irish companies between them. Opsona Therapeutics Limited has 26 shareholders. This Irish company shares its Eircode with at least 8 other companies.
| Company Name: | Opsona Therapeutics Limited |
| Company Status: | STRIKE OFF LISTED |
| Company Address: | 2nd Floor Ashford House, Tara Street, Dublin 2 |
| Telephone: | +353 (0)1 677 0223 |
| Website: | www.opsona.com |
| Key Executive: | Luke O'Neill |
| Company Size: | Log-In To View |
| Disclaimer | Other Details |
|---|---|
| Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us. | |
Luke O'Neill is a Company Director of Opsona Therapeutics Limited since 2007 and a listed Director of 3 other companies.
Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.
Similar Companies - Create a marketing list of similar companies
The latest documents filed with the Companies Registration Office for Opsona Therapeutics Limited (which can include the Account Details) are listed below.
| CRO Document | Effective Date | Received By CRO | View Now | |
|---|---|---|---|---|
| B1 ANNUAL RETURN | 09/09/2016 | 04/01/2018 | Join Up | |
| ACCOUNT DETAILS | 31/12/2015 | 04/01/2018 | Join Up | |
| OTHER DIRECTORSHIP LIST | 09/09/2016 | 04/01/2018 | Join Up | |
| B7 NOTICE OF CONSOLIDATION, DIVISION, CONVERSION | 20/12/2017 | 21/12/2017 | Join Up | |
| NOTICE OF INCREASE IN NOMINAL CAPITAL | 20/12/2017 | 21/12/2017 | Join Up | |
| THIS COMPANY HAS 162 OTHER DOCS » | ||||
View CRO company documents and company reports any Irish company or business with ease.
View the Latest Credit Report and Credit Limit on Opsona Therapeutics Limited.
| Company Status: | Strike Off Listed |
| Latest Credit Movement: |  |
| Date of Last Movement: | 18/06/2018 |
| Latest Accounts Filed: | 04/01/2018 |
| Report Based on Accounts: | 31/12/2015 |
| Next Set of Accounts Due: | 09/09/2017 |
| Overdue: | Yes |
| Credit Score: | Join-Up to View |
To View the latest Credit Rating or Credit Limit on Opsona Therapeutics Limited simply click 'Log-In' or 'Join-Up' below.
Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.
Satisfy due diligence requirments on Opsona Therapeutics Limited in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Opsona Therapeutics Limited and Anti-Money Laundering checks (AML checks) on Opsona Therapeutics Limited
| Director: | Peter Arthur James Benson |
| Director: | Bernd Robert Seizinger |
| Other Directors: | Opsona Therapeutics Limited has 7 other Directors. |
| Company Type: | LTD - Private Company Limited By Shares |
| Number of Shareholders: | 26 |
Log-in now to run Due Diligence checks and Compliance checks on Opsona Therapeutics Limited or click Join-up to get started.
Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.
More people choose Vision-net over any other search service... ask us why?
01/05/2018
Company start-ups remain strong while insolvencies fall in the first quarter of 2018
01/05/2018
2017 was a record year for company start-ups in Ireland while insolvencies went through a levelling off period.
08/02/2018
We are in acceleration mode and Ireland has taken its place as Europe's fastest growing economy. Many aspects of that recovery are demonstrated in our 2017 Annual Review.
08/01/2018
Vision-net has been acquired by leading fintech company, CRIF.
